454 related articles for article (PubMed ID: 34070384)
1. From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy.
Di Gregorio E; Miolo G; Saorin A; Steffan A; Corona G
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070384
[TBL] [Abstract][Full Text] [Related]
2. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
[TBL] [Abstract][Full Text] [Related]
3. Oncometabolites: Unconventional triggers of oncogenic signalling cascades.
Sciacovelli M; Frezza C
Free Radic Biol Med; 2016 Nov; 100():175-181. PubMed ID: 27117029
[TBL] [Abstract][Full Text] [Related]
4. Gerometabolites: the pseudohypoxic aging side of cancer oncometabolites.
Menendez JA; Alarcón T; Joven J
Cell Cycle; 2014; 13(5):699-709. PubMed ID: 24526120
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria and Cancer.
Zong WX; Rabinowitz JD; White E
Mol Cell; 2016 Mar; 61(5):667-676. PubMed ID: 26942671
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria: The metabolic switch of cellular oncogenic transformation.
Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
[TBL] [Abstract][Full Text] [Related]
7. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy.
Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Saavedra E; Moreno-Sánchez R
Mol Aspects Med; 2010 Apr; 31(2):145-70. PubMed ID: 20206201
[TBL] [Abstract][Full Text] [Related]
8. Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory.
Collins RRJ; Patel K; Putnam WC; Kapur P; Rakheja D
Clin Chem; 2017 Dec; 63(12):1812-1820. PubMed ID: 29038145
[TBL] [Abstract][Full Text] [Related]
9. Oncometabolites: linking altered metabolism with cancer.
Yang M; Soga T; Pollard PJ
J Clin Invest; 2013 Sep; 123(9):3652-8. PubMed ID: 23999438
[TBL] [Abstract][Full Text] [Related]
10. Detection, mechanisms, and therapeutic implications of oncometabolites.
Cai Y; Wang Z; Guo S; Lin C; Yao H; Yang Q; Wang Y; Yu X; He X; Sun W; Qiu S; Guo Y; Tang S; Xie Y; Zhang A
Trends Endocrinol Metab; 2023 Dec; 34(12):849-861. PubMed ID: 37739878
[TBL] [Abstract][Full Text] [Related]
11. Unraveling the mystery of cancer metabolism in the genesis of tumor-initiating cells and development of cancer.
Zhang G; Yang P; Guo P; Miele L; Sarkar FH; Wang Z; Zhou Q
Biochim Biophys Acta; 2013 Aug; 1836(1):49-59. PubMed ID: 23523716
[TBL] [Abstract][Full Text] [Related]
12. Mitofusins, from Mitochondria to Metabolism.
Schrepfer E; Scorrano L
Mol Cell; 2016 Mar; 61(5):683-694. PubMed ID: 26942673
[TBL] [Abstract][Full Text] [Related]
13. The role of mitochondria in the oncogenic signal transduction.
Frezza C
Int J Biochem Cell Biol; 2014 Mar; 48():11-7. PubMed ID: 24397955
[TBL] [Abstract][Full Text] [Related]
14. Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change.
Zhou Z; Ibekwe E; Chornenkyy Y
Antioxidants (Basel); 2018 Jan; 7(1):. PubMed ID: 29342092
[TBL] [Abstract][Full Text] [Related]
15. Connections between metabolism and epigenetics in cancers.
Thakur C; Chen F
Semin Cancer Biol; 2019 Aug; 57():52-58. PubMed ID: 31185282
[TBL] [Abstract][Full Text] [Related]
16. Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain.
Garcia-Heredia JM; Carnero A
Oncotarget; 2015 Dec; 6(39):41582-99. PubMed ID: 26462158
[TBL] [Abstract][Full Text] [Related]
17. The Tricarboxylic Acid Cycle at the Crossroad Between Cancer and Immunity.
Scagliola A; Mainini F; Cardaci S
Antioxid Redox Signal; 2020 Apr; 32(12):834-852. PubMed ID: 31847530
[No Abstract] [Full Text] [Related]
18. Harnessing impaired energy metabolism in cancer cell: small molecule- mediated ways to regulate tumorigenesis.
Govardhan KS; Ramyasri K; Kethora D; Ravishekar Y; Prasenjit M
Anticancer Agents Med Chem; 2011 Mar; 11(3):272-9. PubMed ID: 21434854
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated metabolism contributes to oncogenesis.
Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
[TBL] [Abstract][Full Text] [Related]
20. Learning from oncocytic tumors: Why choose inefficient mitochondria?
Gasparre G; Romeo G; Rugolo M; Porcelli AM
Biochim Biophys Acta; 2011 Jun; 1807(6):633-42. PubMed ID: 20732299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
